Whitehawk Therapeutics
WHWK
68 hedge funds and large institutions have $159M invested in Whitehawk Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 10 closing their positions.
130% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 10
24% more funds holding
Funds holding: 55 → 68 (+13)
2.36% more ownership
Funds ownership: 60.85% → 63.21% (+2.4%)
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
27% less capital invested
Capital invested by funds: $219M → $159M (-$59.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.8M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$5.69M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.91M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.03M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$5.36M |
| 2 |
VA
VR Adviser
New York
|
-$5.29M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.8M |
| 5 |
Millennium Management
New York
|
-$2.54M |
WHWK Hedge Fund Activity: Q2 2022 in Review
68 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q2 2022, worth a combined $159M — down 27% from $219M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new WHWK positions and 10 closed out — a net gain of 13 holders — while 15 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $8.8M. The largest seller was RK Capital Management (Colorado), exiting entirely with an estimated $5.36M sold.
- 68 institutional investors held Whitehawk Therapeutics (WHWK) as of Q2 2022, up from 55 in Q1 2022.
- Funds reported $159M of Whitehawk Therapeutics stock for Q2 2022, down 27% quarter-over-quarter.
- 23 funds opened new Whitehawk Therapeutics positions in Q2 2022 and 10 closed out, a net change of +13 holders.
- The largest Whitehawk Therapeutics buyer in Q2 2022 was BlackRock, an estimated $8.8M added.
- The largest Whitehawk Therapeutics seller in Q2 2022 was RK Capital Management (Colorado), an estimated $5.36M sold.
Based on aggregated 13F filings for Q2 2022.